These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38873251)

  • 1. Prognostic models for colorectal cancer recurrence using carcinoembryonic antigen measurements.
    Mohammadian Rad N; Sosef O; Seegers J; Koolen LJER; Hoofwijk JJWA; Woodruff HC; Hoofwijk TAGM; Sosef M; Lambin P
    Front Oncol; 2024; 14():1368120. PubMed ID: 38873251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning for predicting colon cancer recurrence.
    Kayikcioglu E; Onder AH; Bacak B; Serel TA
    Surg Oncol; 2024 Jun; 54():102079. PubMed ID: 38688191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
    Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
    Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
    BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer.
    Zhou S; Sheng N; Ren J; He Q; Zhang Y; Gong J; Wang Z
    Front Oncol; 2021; 11():741309. PubMed ID: 34692522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting mortality and recurrence in colorectal cancer: Comparative assessment of predictive models.
    Alinia S; Asghari-Jafarabadi M; Mahmoudi L; Roshanaei G; Safari M
    Heliyon; 2024 Mar; 10(6):e27854. PubMed ID: 38515707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer.
    Uejima C; Saito H; Tada Y; Tanio A; Murakami Y; Yamamoto M; Matsunaga T; Fukumoto Y; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Fujiwara Y
    Yonago Acta Med; 2021 May; 64(2):176-183. PubMed ID: 34025192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III.
    Kim HS; Lee MR
    Ann Coloproctol; 2013 Aug; 29(4):155-9. PubMed ID: 24032116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexplained increases in serum carcinoembryonic antigen levels in colorectal cancer patients during the postoperative follow-up period: an analysis of its incidence and longitudinal pattern.
    Nozawa H; Yokota Y; Emoto S; Yokoyama Y; Sasaki K; Murono K; Abe S; Sonoda H; Shinagawa T; Ishihara S
    Ann Med; 2023; 55(2):2246997. PubMed ID: 37963211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carcinoembryonic antigen pre-operative level in colorectal cancer: revisiting risk stratification.
    Iacuzzo C; Germani P; Troian M; Cipolat Mis T; Giudici F; Osenda E; Bortul M; de Manzini N
    ANZ J Surg; 2021 Jun; 91(6):E367-E374. PubMed ID: 33870621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of a nomogram constructed from CEA, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer.
    Wang K; Ma L; Chen L; Jiang Y; Liu N; Cai J; Zhang Y
    Cancer Biomark; 2023; 38(4):537-549. PubMed ID: 37980649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.
    Ying HQ; Chen W; Xiong CF; Wang Y; Li XJ; Cheng XX
    Cancer Cell Int; 2022 Mar; 22(1):137. PubMed ID: 35346200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.